Skip to main content
  1. Home
  2. Services
  3. Research
  4. Active Research

Active Research

Skip to content

  • A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

    Primary Investigator: Zhao, MD, Sibo

    IRB ID: 2021-071 (OPEN)

  • A Phase 3 Study of Selumetinib (NSC# 748727, IND# 77782) or Selumetinib in Combination with Vinblastine for non-NF1, non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations

    Primary Investigator: Zhao, MD, Sibo

    IRB ID: 2021-017 (TEMPORARILY CLOSED TO ACCRUAL)

  • SJiMB21, Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children with Newly Diagnosed Medulloblastoma

    Primary Investigator: Zhao, MD, Sibo

    IRB ID: 2023-057 (OPEN)

  • Tissue Banking- Collecting and Banking Human Tissue Samples for Future Use

    Primary Investigator: Zhao, MD, Sibo

    IRB ID: 2020-093 (OPEN)